Apex Biotechnology Corp
TWSE:1733
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
26.5
37.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| TW |
|
Apex Biotechnology Corp
TWSE:1733
|
2.9B TWD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.8B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
137.9B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.8B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.2B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.5B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.8B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.7B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37B USD |
Loading...
|
Market Distribution
| Min | -21 347.1% |
| 30th Percentile | 0.7% |
| Median | 5% |
| 70th Percentile | 11.5% |
| Max | 698% |
Other Profitability Ratios
Apex Biotechnology Corp
Glance View
Apex Biotechnology Corp. engages in the research, development, manufacture and sell of biotechnological products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2001-09-17. The firm primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The firm distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Apex Biotechnology Corp is 7.9%, which is above its 3-year median of 7.3%.
Over the last 3 years, Apex Biotechnology Corp’s Operating Margin has increased from 7.6% to 7.9%. During this period, it reached a low of 5.3% on Jun 30, 2024 and a high of 9.6% on Jun 30, 2025.